The impact of HEr-2 status on loval recurrence in women with stage I-II breast cancer treated with breast-conserving therapy.

Detalles Bibliográficos
Publicado en:Breast Journal Vol. 12; no. 5; pp. 431 - 437
Autores principales: Harris EER, Hwang W, Lee EA, Cengel KA, Feldman MD, DeMichele A, Kao G, Solin LJ
Formato: research Journal Article
Publicado: Wiley-Blackwell Sep2006
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105998048&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 105998048
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1075122X
        ET6
      jtl: Breast Journal
      issn: 1075122X
      maglogo: Y
    pubinfo:
      dt: Sep2006
      vid: 12
      iid: 5
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        105998048
        105998048
        2009305177
        10.1111/j.1075-122x.2006.00297.x
        NLM16958961
        105998048
      ppf: 431
      ppct: 6
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: The impact of HEr-2 status on loval recurrence in women with stage I-II breast cancer treated with breast-conserving therapy.
      aug:
        au:
          Harris EER
          Hwang W
          Lee EA
          Cengel KA
          Feldman MD
          DeMichele A
          Kao G
          Solin LJ
        affil: Moffitt Cancer Center, 12902 Magnolia Dr., Tampa, FL 33612; HarrisE@moffitt.usf.edu
      sug:
        subj:
          Breast Neoplasms
          Carcinoma, Ductal, Breast
          Lumpectomy
          Neoplasm Recurrence, Local
          Receptors, Cell Surface Analysis
          Tumor Markers, Biological Analysis
          Adult
          Aged
          Aged, 80 and Over
          Breast Neoplasms Pathology
          Breast Neoplasms Surgery
          Carcinoma, Ductal, Breast Pathology
          Carcinoma, Ductal, Breast Surgery
          Female
          Immunohistochemistry
          Middle Age
          Neoplasm Staging
          Retrospective Design
          Human
          Adult: 19-44 years
          Aged: 65+ years
          Aged, 80 & over
          Middle Aged: 45-64 years
          Female
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N